血脑屏障技术市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00021883
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 157
Buy Now

血脑屏障技术市场预计将从 2021 年的 104105 万美元增至 2028 年的 510194 万美元;据估计,从 2021 年到 2028 年,复合年增长率为 25.5%。

大脑被称为脑脊液的保护液和称为脑膜的保护膜包围。血脑屏障是大脑血管、细胞和其他组成脑组织的成分之间存在的另一种保护元素。血脑屏障保护大脑免受血液中可能存在的致病病原体/毒素的侵害。它阻止异物进入脑组织。它还阻止用于治疗神经变性和神经炎症事件的救生药物的通过。因此,用于跨血脑屏障输送药物的技术不同于用于将药物输送到身体其他部位的技术。

战略洞察

血脑屏障技术市场根据技术进行细分,应用和地理。按地域划分,市场进一步细分为北美、欧洲、亚太地区、中东和非洲、以及南美洲和中美洲。该报告提供了对市场的见解和深入分析,强调市场趋势、技术进步和市场动态等参数,以及对全球领先市场参与者的竞争格局的分析。    

血脑屏障技术市场利润丰厚的区域


 

市场洞察

神经系统疾病的患病率不断上升推动血脑屏障技术市场增长

神经系统疾病,如癫痫和惊厥、帕金森病、痴呆、自闭症、阿尔茨海默病、脑肿瘤和脑瘫会影响人体的大脑和神经。在美国,神经系统疾病的患病率正在增加。根据美国疾病控制与预防中心 (CDC) 的数据,阿尔茨海默病是美国十大死因之一。 2020年,阿尔茨海默病影响了该国580万人。同样,根据帕金森病基金会患病率项目的估计,2020年美国记录了93万例帕金森病病例。此外,根据阿尔茨海默病协会的估计,超过600万美国人患有阿尔茨海默病,预计这一数字将达到~到 2050 年,这一数字将达到 1300 万。此外,自 COVID-19 大流行以来,美国因阿尔茨海默病和痴呆症死亡的人数增加了 16%。另一方面,2000 年至 2019 年期间,阿尔茨海默病造成的死亡人数增加了 145%。

癫痫是一种非传染性慢性脑部疾病,影响所有年龄段的人。据世界卫生组织 (WHO) 统计,全球约有 5000 万人患有癫痫症,使其成为世界上最常见的神经系统疾病之一。约 80% 的癫痫患者生活在低收入和中等收入国家。同一消息来源估计,如果接受正确的诊断和治疗,高达 70% 的癫痫患者可以摆脱癫痫发作。痴呆症目前是所有疾病中第七大死因,也是全球老年人残疾和成瘾的主要原因之一。据世界卫生组织称,全球有超过 5500 万人患有痴呆症,并且每年约有 1000 万新病例。这种情况是由多种主要或继发影响大脑的疾病和损伤引起的。阿尔茨海默病是最常见的痴呆症,可能导致 60% 至 70% 的痴呆症病例。因此,神经系统疾病的日益流行需要先进的血脑屏障技术进行治疗,这推动了市场的增长。

老年人口的增加和与年龄相关的神经疾病患病率的上升有助于血脑屏障技术市场的增长

一些神经系统疾病,如中风、神经病、阿尔茨海默病和帕金森病在老年人群中更为常见,并且随着预期寿命的提高,其患病率也在增加。据世界卫生组织称,全球人口正在迅速老龄化。 2015年至2050年,世界60岁以上人口将增加近一倍,比例将从12%增至22%。老年人中的精神和神经系统疾病可能占该年龄段总伤残调整生命年 (DALY) 的 6.6%。此外,根据同一来源,约 15% 60 岁及以上的成年人患有精神障碍。

根据 CDC 的数据,阿尔茨海默病是第五大病因65 岁及以上人群的死亡人数。此外,患有阿尔茨海默病的人数每五年就会翻一番。 2020 年,阿尔茨海默病影响了约 580 万属于该年龄段的美国人,到 2060 年,这一数字预计将增加近三倍,达到 1400 万。神经系统疾病引起的死亡率也在增加。据阿尔茨海默氏症协会称,在美国,每年有三分之一的老年人死于阿尔茨海默氏症或痴呆症。

因此,与年龄相关的神经系统疾病的患病率不断上升,推动了对血脑屏障技术的需求,以改善人们的健康状况。药物输送。

技术见解               

根据技术,全球血脑屏障技术市场分为双特异性抗体RMT方法、特洛伊木马方法、增加渗透性、被动扩散和其他非侵入性 BBB 技术。 2020年,渗透率不断增加的细分市场占据了最大的市场份额。然而,预计试剂细分市场将在 2021 年至 2028 年实现最高的复合年增长率。血脑屏障(BBB)通透性增加与内皮间连接复合体的重塑和脑内皮细胞之间间隙的形成(细胞旁途径)以及脑内皮细胞顶端和基底侧之间的密集胞饮囊泡运输(跨细胞途径)有关。增加渗透性细分市场的增长可归因于人们对治疗许多神经和中枢神经系统疾病的研究活动的日益关注。   

应用洞察

根据应用,血脑屏障技术市场分为阿尔茨海默病和老年痴呆症。脑病、癫痫、帕金森病、多发性硬化症、亨特综合症、脑癌等。帕金森病领域预计将在 2021 年占据最大的市场份额。

按技术划分的血脑屏障技术市场 – 2021年和2028年


 

产品发布、并购被高度采用全球血脑屏障技术市场参与者的策略。下面列出了近期的一些关键市场动态:

2021 年 12 月,礼来公司收购了生物技术公司 Prevail Therapeutics。交易完成后,礼来公司计划为患有神经退行性疾病(包括帕金森氏症)的患者创建基因治疗计划。

2020年10月,百时美施贵宝宣布ZEPOSIA(ozanimod)获得加拿大卫生部批准用于治疗复发缓解型多发性硬化症(RRMS)患者,以降低临床病情加重的频率。

>

根据伦敦帝国学院四位学者的初步(尚未经过同行评审)研究以及其他基于研究的证据,COVID-19 感染可能会导致神经系统问题。这种观点是在第一波大流行期间形成的。血脑屏障是内皮细胞的半透膜,使大脑与身体其他部分的成分和机制分开。单核细胞是一种白细胞,当 SARS-CoV-2 进入血液时,它会被激活,作为人体防御机制的一部分。为了让单核细胞穿过血脑屏障,需要激活一个复杂的机制。根据同一项研究,“血脑屏障有助于受感染和激活的单核细胞进入中枢神经系统,从而使 SARS-CoV-2 病毒能够通过松弛的血脑屏障。因此,对血脑屏障技术的需求不断增长检测 COVID-19 患者的神经系统问题对市场增长产生积极影响。

血脑屏障技术 - 市场细分

全球血液脑屏障技术市场分为技术、应用和地域。在技术方面,市场分为双特异性抗体RMT方法、特洛伊木马方法、增加渗透性、被动扩散和其他非侵入性BBB技术。血脑屏障技术市场细分为阿尔茨海默病、癫痫、帕金森病、多发性硬化症、亨特综合症、脑癌等。

< h3>公司简介
  • Teva Pharmaceutical Industries Ltd.
  • F.霍夫曼-拉罗氏有限公司
  • 礼来公司。
  • 百时美施贵宝公司
  • 辉瑞公司
  • 强生公司Johnson Services, Inc.
  • Fabre-Kramer Pharmaceuticals, Inc.
  • Bioasis Technologies Inc.
  • Abliva AB
  • JCR Pharmaceuticals Co.有限公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is blood brain barrier technologies?

The brain is surrounded by protective fluid known as cerebrospinal fluid and a protective membrane called the meninges. Similar another protective element is the blood brain barrier. this is a barrier between the brain's blood vessels and the cells and other components that together make up brain tissue. The blood brain barrier protects against disease-causing pathogens/toxins that may be present in the blood. It blocks the passage of foreign substances entering the brain tissue. It also blocks the passage of life-saving drugs used to treat neurodegeneration and neuroinflammation events. Thus, different technologies are used to deliver drugs across blood brain barrier.

What are the driving factors for the blood brain barrier technologies market across the globe?

Key factors driving the growth of the market are growing prevalence of neurological disorders and increasing geriatric population and neurological disorders associated with age are among the key factors driving the market.

Which are the key players in the blood brain barrier technologies market?

Key players in the market are Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Eli Lilly and Company., Bristol-Myers Squibb Company, Pfizer, Inc., Johnson and Johnson Services, Inc., Fabre-Kramer Pharmaceuticals, Inc., Bioasis Technologies Inc., Abliva AB, and JCR Pharmaceuticals Co., Ltd. among others.

What are the key trends in the blood brain barrier technologies market?

Nanoparticles for brain drug delivery is likely to act as trend the market growth in the comping years.

Which is the most influencing segment growing in the blood brain barrier technologies market report?

Increasing permeability is the most influencing segment growing in the blood brain barrier technologies market.

What are the opportunities for new blood brain barrier technologies market entrants?

Large number of product approvals and launches are likely to fuel the market growth in the comping years.

Which region is lucrative for the blood brain barrier technologies market?

Asia-Pacific is the lucrative for the blood brain barrier technologies market.

The List of Companies - Blood Brain Barrier Technologies Market

  1. Teva Pharmaceutical Industries Ltd.
  2. F. Hoffmann-La Roche Ltd.
  3. Eli Lilly and Company
  4. Bristol-Myers Squibb Company
  5. Pfizer, Inc.
  6. Johnson and Johnson Services, Inc.
  7. Fabre-Kramer Pharmaceuticals, Inc.
  8. Bioasis Technologies Inc.
  9. Abliva AB
  10. JCR Pharmaceuticals Co., Ltd.  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports